D&D Pharmatech Inc. (KOSDAQ: 347850)
South Korea flag South Korea · Delayed Price · Currency is KRW
47,000
-100 (-0.21%)
Dec 20, 2024, 9:00 AM KST

D&D Pharmatech Revenue

D&D Pharmatech had revenue of 1.94B KRW in the quarter ending September 30, 2024, a decrease of -72.27%. This brings the company's revenue in the last twelve months to 8.19B, down -51.85% year-over-year. In the year 2023, D&D Pharmatech had annual revenue of 18.68B with 2,958.97% growth.

Revenue (ttm)
8.19B
Revenue Growth
-51.85%
P/S Ratio
56.41
Revenue / Employee
389.85M
Employees
21
Market Cap
495.51B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202318.68B18.07B2,958.97%
Dec 31, 2022610.57M-753.54M-55.24%
Dec 31, 20211.36B--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition